Matthew Burnell

MRC Clinical Trials Unit at UCL — United Kingdom

Medicine · Health Sciences

40h-index8.7kcitations136works3.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Ovarian cancer diagnosis and treatment(53), Endometrial and Cervical Cancer Treatments(30), BRCA gene mutations in cancer(25), Endometriosis Research and Treatment(19), Colorectal Cancer Screening and Detection(12)

Publications136 total

Estimating the ovarian cancer CA-125 preclinical detectable phase, in-vivo tumour doubling time, and window for detection in early stage: an exploratory analysis of UKCTOCS
EBioMedicine·2025· 10 citedOpen Access
How One Community Exercise Program for People Living With Cancer Impacted Health Care Utilization
Oncology Issues·2024
Outcomes of minimal access retroperitoneal para-aortic lymphadenectomy in patients with locally advanced cervical cancer
Journal of Obstetrics and Gynaecology·2024· 1 citedOpen Access
Estimating the Ovarian Cancer CA-125 Preclinical Detectable Phase, In-Vivo Tumour Doubling Time, and Window for Detection in Early Stage: An Exploratory Analysis of UKCTOCS
SSRN Electronic Journal·2024· 3 citedOpen Access
Embedding Patient Input in Outcome Measures for Long‐Term Disease‐Modifying Parkinson Disease Trials
Movement Disorders·2023· 10 citedOpen Access
Ovarian cancer symptoms in pre-clinical invasive epithelial ovarian cancer – An exploratory analysis nested within the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)
Gynecologic Oncology·2023· 8 citedOpen Access
Carboplatin dosage: prospective evaluation of a simple formula based on renal function.
Journal of Clinical Oncology·2023· 63 cited
Tumour stage, treatment, and survival of women with high-grade serous tubo-ovarian cancer in UKCTOCS: an exploratory analysis of a randomised controlled trial
The Lancet Oncology·2023· 49 citedOpen Access
Insights from UKCTOCS for design, conduct and analyses of large randomised controlled trials
Health Technology Assessment·2023· 5 citedOpen Access
Outcome Measures for Disease-Modifying Trials in Parkinson’s Disease: Consensus Paper by the EJS ACT-PD Multi-Arm Multi-Stage Trial Initiative
Journal of Parkinson s Disease·2023· 19 citedOpen Access
Mortality impact, risks, and benefits of general population screening for ovarian cancer: the UKCTOCS randomised controlled trial
Health Technology Assessment·2023· 28 citedOpen Access
Data from Comparison of Longitudinal CA125 Algorithms as a First-Line Screen for Ovarian Cancer in the General Population
2023Open Access
Data from Comparison of Longitudinal CA125 Algorithms as a First-Line Screen for Ovarian Cancer in the General Population
2023Open Access
Supplementary Table 1 from Comparison of Longitudinal CA125 Algorithms as a First-Line Screen for Ovarian Cancer in the General Population
2023Open Access
Supplementary Table 1 from Comparison of Longitudinal CA125 Algorithms as a First-Line Screen for Ovarian Cancer in the General Population
2023Open Access
Towards a multi-arm multi-stage platform trial of disease modifying approaches in Parkinson’s disease
Brain·2023· 28 citedOpen Access
Why Did Downstaging in the United Kingdom Collaborative Trial of Ovarian Cancer Screening (UKCTOCS) Not Result in a Mortality Benefit: Exploratory Analysis of a Randomised Controlled Trial
SSRN Electronic Journal·2023Open Access
2022-RA-1465-ESGO Randomised trial of population based BRCA testing in Ashkenazi Jews: long term secondary lifestyle behavioural outcomes
International Journal of Gynecological Cancer·2022Open Access
Randomised trial of population‐based <scp><i>BRCA</i></scp> testing in Ashkenazi Jews: long‐term secondary lifestyle behavioural outcomes
BJOG An International Journal of Obstetrics & Gynaecology·2022· 6 citedOpen Access
Association of adult attachment with delays in accessing specialist care in women with ovarian cancer
Journal of Psychosocial Oncology·2022· 3 citedOpen Access
page 1 of 7Next →

Frequent Co-authors

Usha Menon(39), Ian Jacobs(37), Andy Ryan(24), Aleksandra Gentry‐Maharaj(24), Ranjit Manchanda(19), Mahesh Parmar(16), Naveena Singh(14), Steven J. Skates(14), Anne Dawnay(13), Tim Mould(13), Alistair McGuire(13), Jatinderpal Kalsi(12), Robert Woolas(12), Lesley Fallowfield(12), Simon Leeson(11), Aarti Sharma(11), Karin Williamson(11), Mourad W. Seif(10), Nazar N. Amso(9), Stuart Campbell(9)